Ovation Life Sciences, LLC, a Cambridge, MA-based scientific data company, raised $1.5m in funding.
Backers included StageDotO, and existing investor Longfellow Ventures.
The company will use the funds to continue the development of its scientific SaaS platforms.
Led by Barry Wark, Chief Executive Officer, Ovation provides cloud-based data management, collaboration and laboratory coordination services to visualize and explore the relationships between samples, data, analyses, and conclusions for the entire bench to bedside lifecycle.
The company also announced a partnership with iGeneTRAiN – is a multi-institutional team of transplant surgeons and scientists co-led by researchers from the Perelman School of Medicine at the University of Pennsylvania – to use Ovation Research to maximize collaboration capabilities across iGeneTRAiN’s transplant consortium.
iGeneTRAiN will use Ovation Research Pro to facilitatie the integration of genomic and other omic datasets in over 48,000 samples from more than 30 studies, across 12 countries.